Suppr超能文献

花生四烯酸代谢产物在肾脏稳态中的作用。非甾体抗炎药的肾功能以及生化、组织学和临床效应与药物相互作用。

The role of arachidonic acid metabolites in renal homeostasis. Non-steroidal anti-inflammatory drugs renal function and biochemical, histological and clinical effects and drug interactions.

作者信息

Dunn M

出版信息

Drugs. 1987;33 Suppl 1:56-66. doi: 10.2165/00003495-198700331-00009.

Abstract

Prostaglandins (PG) E2 and I2 have a number of effects on renal function, such as causing vasodilatation, increasing the glomerular filtration rate, sodium chloride excretion, water excretion, and stimulating renin secretion. Studies in dogs have shown that reductions in renal blood flow associated with angiotensin II administration are accompanied by increased synthesis of vasodilatory PGE2 followed by a compensatory increase in blood flow. Moreover, in rats and dogs, non-steroidal anti-inflammatory drugs (NSAIDs) markedly augment the reductions in renal blood flow associated with angiotensin II administration. Clinical use of NSAIDs can induce 1 of 2 types of renal syndromes in patients with certain predisposing conditions. These syndromes are ischaemic acute renal failure and papillary necrosis or, rarely, an idiosyncratic reaction. It is believed that the effects of cyclo-oxygenase inhibitors on renal function are most important in patients with these predisposing conditions because in many of these conditions there is increased synthesis of renal PGE2 and PGI2 to compensate for abnormally high plasma concentrations of vasoconstrictor hormones. Angiotensin II produces a concentration-dependent contraction of isolated rat glomeruli or mesangial cells which is potentiated by pretreatment with indomethacin or meclofenamate. Pretreatment with arachidonic acid, or addition of exogenous PGE2, inhibits the angiotensin-mediated glomerular contraction. Stable endoperoxide analogues, which mimic the effects of thromboxane A2, induce a similar glomerular contraction to angiotensin. Similar findings were recorded using isolated rat mesangial cells. Mesangial cell contraction is believed to reduce the filtration surface area of the glomerulus and, therefore, the glomerular filtration rate. In these cells angiotensin II not only induces contraction but also increases the rate of synthesis of PGE2. Associated with the acute reduction in renal function after induction of an immune glomerular nephritis in rats, there is a marked increase in glomerular thromboxane synthesis. The thromboxane synthetase inhibitor dazoxiben inhibits this increase and prevents the acute renal changes which occur in untreated animals during the first 3 hours after antibody injection. However, thromboxane synthetase inhibitors have no influence on renal function when nephrotoxic serum nephritis has been established for 14 days. In conclusion, maintenance of adequate renal function would seem to be dependent on a balance of substances causing mesangial relaxation (PGE2 and PGI2) and contraction (thromboxanes, endoperoxides and leukotrienes).(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

前列腺素(PG)E2和I2对肾功能有多种影响,如引起血管舒张、增加肾小球滤过率、氯化钠排泄、水排泄以及刺激肾素分泌。对犬的研究表明,给予血管紧张素II后肾血流量减少,同时血管舒张性PGE2的合成增加,随后血流量出现代偿性增加。此外,在大鼠和犬中,非甾体抗炎药(NSAIDs)显著增强了与给予血管紧张素II相关的肾血流量减少。NSAIDs在临床使用时,可在患有某些易感疾病的患者中诱发两种肾综合征中的一种。这些综合征为缺血性急性肾衰竭和乳头坏死,或很少见的特异反应。据信,环氧化酶抑制剂对肾功能的影响在患有这些易感疾病的患者中最为重要,因为在许多此类疾病中,肾PGE2和PGI2的合成增加,以补偿血管收缩激素血浆浓度异常升高的情况。血管紧张素II可使离体大鼠肾小球或系膜细胞产生浓度依赖性收缩,吲哚美辛或甲氯芬那酸预处理可增强这种收缩。花生四烯酸预处理或添加外源性PGE2可抑制血管紧张素介导的肾小球收缩。模拟血栓素A2作用的稳定内过氧化物类似物可诱导与血管紧张素类似的肾小球收缩。使用离体大鼠系膜细胞也记录到了类似的结果。系膜细胞收缩被认为会减少肾小球的滤过表面积,从而降低肾小球滤过率。在这些细胞中,血管紧张素II不仅可诱导收缩,还可增加PGE2的合成速率。在大鼠免疫性肾小球肾炎诱导后肾功能急性降低的同时,肾小球血栓素合成显著增加。血栓素合成酶抑制剂达唑氧苯可抑制这种增加,并防止未治疗动物在注射抗体后的最初3小时内出现急性肾脏变化。然而,当肾毒性血清肾炎已形成14天时,血栓素合成酶抑制剂对肾功能没有影响。总之,维持足够的肾功能似乎依赖于引起系膜舒张(PGE2和PGI2)和收缩(血栓素、内过氧化物和白三烯)的物质之间的平衡。(摘要截短至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验